119
Participants
Start Date
January 22, 2018
Primary Completion Date
August 31, 2022
Study Completion Date
September 23, 2022
NT-501
"Each NT-501 implant consisted of hCNTF-secreting NTC-201-6A.02 cells encapsulated within supportive matrices and surrounded by a semipermeable polymer membrane.~The NTC-201-6A cells continuously secrete CNTF from the NT-501 implant into the vitreous cavity. Implanted by a qualified Health Care Professional."
Sham
The sham surgery involved a superficial conjunctival incision performed under local anesthetic and closure with a single suture.
Save Sight Institute, Sydney, Sydney
Centre for Eye Research Australia Macular Research Unit, East Melbourne
Flaum Eye - University of Rochester, Rochester
University of Rochester Strong Memorial Hospital, Rochester
Scheie Eye Institute - University of Pennsylvania, Philadelphia
Elman Retina Group, PA, Baltimore
Palmetto Retina Center, West Columbia
Emory University Eye Center, Atlanta
Southeastern Retina Associates, PC, Knoxville
Cincinnati Eye Institute, Cincinnati
University of Michigan, Kellogg Eye Center, Ann Arbor
St. Franziskus, Muenster, Münster
University of Bonn, Bonn
Mayo Clinic, Rochester
Northwestern Medical Group, Chicago
The Retina Institute, Chesterfield
Tulsa Retina Consultants, Tulsa
Retina Center of Texas, Southlake
Retina Consultants of Texas, Bellaire
Austin Clinical Research, LLC, Austin
Klinik at Freiberg, Germany, Freiburg im Breisgau
Retina Consultants of Southern Colorado, P.C., Colorado Springs
Retina Vitreous Assoc, Beverly Hills
Retina Northwest, PC, Portland
Massachusetts Eye and Ear Infirmary Ophthalmology Clinical Research Office, Boston
New England Retina Consultants, Springfield
Retina Center of New Jersey - Envision Ocular, LLC, Bloomfield
Lead Sponsor
The Lowy Medical Research Institute Limited
OTHER
Neurotech Pharmaceuticals
INDUSTRY